Look at the promising data for Moderna and Merck’s experimental cancer vaccine and the research suggesting the shingles vaccine can delay dementia.
The world’s most sophisticated drug companies are putting billions into vaccines — despite the political environment
MA
MarketWatch Top StoriesBy Craig Williams
EXECUTIVE SUMMARY
Look at the promising data for Moderna and Merck’s experimental cancer vaccine and the research suggesting the shingles vaccine can delay dementia.
Key Takeaways
- The world’s most sophisticated drug companies are putting billions into vaccines — despite the political environment.
- Look at the promising data for Moderna and Merck’s experimental cancer vaccine and the research suggesting the shingles vaccine can delay dementia.
- Look at the promising data for Moderna and Merck’s experimental cancer vaccine and the research suggesting the shingles vaccine can delay dementia.
Read Complete Original Article
Published originally on MarketWatch Top Stories
